
US Business
Bayer to Buy Gene-Therapy Firm AskBio for Up to $4 Billion
Bayer intends to acquire U.S.-based Asklepios BioPharmaceutical to strengthen the German company’s drugmaking arm, as Bayer continues to reel from its acquisition of crops giant Monsanto.